These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 8661396
1. Mutational analysis of HIV-1 gp160-mediated receptor interference: intracellular complex formation. Martin RA, Nayak DP. Virology; 1996 Jun 15; 220(2):461-72. PubMed ID: 8661396 [Abstract] [Full Text] [Related]
2. Membrane anchorage of gp160 is necessary and sufficient to prevent CD4 transport to the cell surface. Martin RA, Nayak DP. Virology; 1996 Jun 15; 220(2):473-9. PubMed ID: 8661397 [Abstract] [Full Text] [Related]
3. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal. Raja NU, Vincent MJ, Jabbar MA. J Gen Virol; 1993 Oct 15; 74 ( Pt 10)():2085-97. PubMed ID: 8409933 [Abstract] [Full Text] [Related]
4. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing. Koga Y, Nakamura K, Sasaki M, Kimura G, Nomoto K. Virology; 1994 May 15; 201(1):137-41. PubMed ID: 8178478 [Abstract] [Full Text] [Related]
5. Biological properties of recombinant HIV envelope synthesized in CHO glycosylation-mutant cell lines. Fenouillet E, Miquelis R, Drillien R. Virology; 1996 Apr 01; 218(1):224-31. PubMed ID: 8615025 [Abstract] [Full Text] [Related]
12. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum. Kimura T, Nishikawa M, Ohyama A. J Biochem; 1994 May 10; 115(5):1010-20. PubMed ID: 7961587 [Abstract] [Full Text] [Related]
13. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Buonocore L, Rose JK. Nature; 1990 Jun 14; 345(6276):625-8. PubMed ID: 2190096 [Abstract] [Full Text] [Related]
14. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses. Otteken A, Voss G, Hunsmann G. Virology; 1993 May 14; 194(1):37-43. PubMed ID: 8480426 [Abstract] [Full Text] [Related]
15. N-linked glycans in the CD4-binding domain of human immunodeficiency virus type 1 envelope glycoprotein gp160 are essential for the in vivo priming of T cells recognizing an epitope located in their vicinity. Sjölander S, Bolmstedt A, Akerblom L, Horal P, Olofsson S, Morein B, Sjölander A. Virology; 1996 Jan 15; 215(2):124-33. PubMed ID: 8560759 [Abstract] [Full Text] [Related]
16. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes. Callahan KM, Rowell JF, Soloski MJ, Machamer CE, Siliciano RF. J Immunol; 1993 Sep 15; 151(6):2928-42. PubMed ID: 8376762 [Abstract] [Full Text] [Related]
18. The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. Fenouillet E, Jones IM. J Gen Virol; 1995 Jun 15; 76 ( Pt 6)():1509-14. PubMed ID: 7782780 [Abstract] [Full Text] [Related]